Astellas Pharma Inc. reported earnings results for the full year ended March 31, 2024. For the full year, the company reported sales was JPY 1,603,672 million compared to JPY 1,518,619 million a year ago. Net income was JPY 17,045 million compared to JPY 98,714 million a year ago.

Basic earnings per share from continuing operations was JPY 9.51 compared to JPY 54.24 a year ago. Diluted earnings per share from continuing operations was JPY 9.47 compared to JPY 54.09 a year ago.